The premixed insulin NovoMix® 30 has replaced Protaphane in the treatment of high blood sugar related to corticosteroid therapy.
More information about pre-mixed insulins can be found in the section Pre-mixed insulin products.
Intermediate-acting insulin products
NPH insulin Protaphane has most commonly been used in Finland to treat high blood sugar associated with corticosteroid therapy. At the end of 2025, Protaphane will no longer be available.
Updated 2.12.2025